These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 28893955

  • 21. Role of NKG2D and its ligands in the anti-infectious activity of Vγ9Vδ2 T cells against intracellular bacteria.
    Bessoles S, Ni M, Garcia-Jimenez S, Sanchez F, Lafont V.
    Eur J Immunol; 2011 Jun; 41(6):1619-28. PubMed ID: 21469127
    [Abstract] [Full Text] [Related]

  • 22. The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells.
    Höring E, Podlech O, Silkenstedt B, Rota IA, Adamopoulou E, Naumann U.
    Anticancer Res; 2013 Apr; 33(4):1351-60. PubMed ID: 23564772
    [Abstract] [Full Text] [Related]

  • 23. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.
    Campbell TM, McSharry BP, Steain M, Slobedman B, Abendroth A.
    J Virol; 2015 Aug; 89(15):7932-43. PubMed ID: 25995251
    [Abstract] [Full Text] [Related]

  • 24. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
    Textor S, Fiegler N, Arnold A, Porgador A, Hofmann TG, Cerwenka A.
    Cancer Res; 2011 Sep 15; 71(18):5998-6009. PubMed ID: 21764762
    [Abstract] [Full Text] [Related]

  • 25. Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy.
    Ding H, Yang X, Wei Y.
    Int J Mol Sci; 2018 Jan 07; 19(1):. PubMed ID: 29316666
    [Abstract] [Full Text] [Related]

  • 26. The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation.
    Roda-Navarro P, Reyburn HT.
    J Biol Chem; 2009 Jun 12; 284(24):16463-16472. PubMed ID: 19329438
    [Abstract] [Full Text] [Related]

  • 27. Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV.
    El Sobky SA, El-Ekiaby NM, Mekky RY, Elemam NM, Mohey Eldin MA, El-Sayed M, Esmat G, Abdelaziz AI.
    Immunol Lett; 2016 Jan 12; 169():52-60. PubMed ID: 26518141
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels.
    Xu L, Chen X, Shen M, Yang DR, Fang L, Weng G, Tsai Y, Keng PC, Chen Y, Lee SO.
    Mol Oncol; 2018 Mar 12; 12(3):269-286. PubMed ID: 28865178
    [Abstract] [Full Text] [Related]

  • 29. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.
    Raneros AB, Minguela A, Rodriguez RM, Colado E, Bernal T, Anguita E, Mogorron AV, Gil AC, Vidal-Castiñeira JR, Márquez-Kisinousky L, Bulnes PD, Marin AM, Garay MCG, Suarez-Alvarez B, Lopez-Larrea C.
    Oncotarget; 2017 May 09; 8(19):31959-31976. PubMed ID: 28404876
    [Abstract] [Full Text] [Related]

  • 30. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer.
    Smyth MJ, Swann J, Kelly JM, Cretney E, Yokoyama WM, Diefenbach A, Sayers TJ, Hayakawa Y.
    J Exp Med; 2004 Nov 15; 200(10):1325-35. PubMed ID: 15545356
    [Abstract] [Full Text] [Related]

  • 31. Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.
    Shi L, Lin H, Li G, Sun Y, Shen J, Xu J, Lin C, Yeh S, Cai X, Chang C.
    Cancer Lett; 2016 Apr 01; 373(1):45-56. PubMed ID: 26805759
    [Abstract] [Full Text] [Related]

  • 32. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.
    Wittenbrink M, Spreu J, Steinle A.
    Eur J Immunol; 2009 Jun 01; 39(6):1642-51. PubMed ID: 19424970
    [Abstract] [Full Text] [Related]

  • 33. Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses.
    Hilpert J, Grosse-Hovest L, Grünebach F, Buechele C, Nuebling T, Raum T, Steinle A, Salih HR.
    J Immunol; 2012 Aug 01; 189(3):1360-71. PubMed ID: 22730533
    [Abstract] [Full Text] [Related]

  • 34. A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells.
    Chang YH, Connolly J, Shimasaki N, Mimura K, Kono K, Campana D.
    Cancer Res; 2013 Mar 15; 73(6):1777-86. PubMed ID: 23302231
    [Abstract] [Full Text] [Related]

  • 35. The regulatory effect of UL-16 binding protein-3 expression on the cytotoxicity of NK cells in cancer patients.
    Mou X, Zhou Y, Jiang P, Zhou T, Jiang Q, Xu C, Liu H, Zheng T, Yuan G, Zhang Y, Chen D, Mao C.
    Sci Rep; 2014 Aug 20; 4():6138. PubMed ID: 25138242
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands.
    Schulz U, Kreutz M, Multhoff G, Stoelcker B, Köhler M, Andreesen R, Holler E.
    Scand J Immunol; 2010 Oct 20; 72(4):319-31. PubMed ID: 20883317
    [Abstract] [Full Text] [Related]

  • 37. Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells.
    Qi YY, Lu C, Ju Y, Wang ZE, Li YT, Shen YJ, Lu ZM.
    Asian Pac J Cancer Prev; 2014 Oct 20; 15(18):7857-61. PubMed ID: 25292077
    [Abstract] [Full Text] [Related]

  • 38. c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis.
    Nanbakhsh A, Pochon C, Mallavialle A, Amsellem S, Bourhis JH, Chouaib S.
    Blood; 2014 Jun 05; 123(23):3585-95. PubMed ID: 24677544
    [Abstract] [Full Text] [Related]

  • 39. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
    Sourour SK, Aboelenein HR, Elemam NM, Abdelhamid AK, Salah S, Abdelaziz AI.
    Int J Rheum Dis; 2017 Sep 05; 20(9):1237-1246. PubMed ID: 28523761
    [Abstract] [Full Text] [Related]

  • 40. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C, Zhang J, Niu J, Zhou Z, Zhang J, Tian Z.
    Hum Immunol; 2008 Aug 05; 69(8):490-500. PubMed ID: 18619507
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.